The United States continues to lead the PCOS treatment market due to the high prevalence of polycystic ovarian syndrome, increasing obesity rates, and growing awareness of women's reproductive health. Strong investments in pharmaceutical research, favorable reimbursement policies, and widespread access to advanced healthcare services are driving market expansion. The adoption of innovative...